In terms of disease type, the diabetes drugs market has been segmented into type 1 diabetes, type 2 diabetes, gestational diabetes, and impaired glucose tolerance and
impaired fasting glycaemia. Type 2 diabetes has accounted for highest market share due to increasing disposable income and rising prevalence of obesity.
Pathophysiology and aetiology of
impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?
Vaag, "Pathophysiology and aetiology of
impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?," Diabetologia, vol.
A clinical trial of treating
impaired fasting glycaemia by metformin.
Patients with impaired fasting glycaemia also showed a poor functional outcome and a lower rate of discharge to home after acute stroke [34].
Alberti, "Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention," Diabetic Medicine, vol.
Borch-Johnsen, "
Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action," Diabetologia, vol.
Because 2-h plasma glucose results were not available, dysglycaemia was defined as the presence of diabetes or
impaired fasting glycaemia (IFG).
Impaired fasting glycaemia (IFG) was defined as FPG [greater than or equal to] 6.1 mmol [l.sup.-L] [22].
The American Diabetes Association (ADA) defines pre-diabetes as a fasting plasmaglucose (FPG) [greater than or equal to]5.6 mmol/l but <7.0 mmol/l, which is termed
impaired fasting glycaemia (IFG), or an abnormal 2-hour response to a 75 g oral glucose tolerance test (OGTT) of at least 7.8 mmol/l and <11.1 mmol/l, which is termed impaired glucose tolerance (IGT), or an [HbA.sub.1c] of 5.7 - 6.4%.
You have impaired glucose tolerance or
impaired fasting glycaemia.
l You have been diagnosed with impaired glucose tolerance or
impaired fasting glycaemia